ETV Bharat / bharat

DRDO's anti-COVID drug priced at Rs 990

DRDO
DRDO
author img

By

Published : May 28, 2021, 12:43 PM IST

Updated : May 28, 2021, 6:41 PM IST

12:39 May 28

DRDO's anti-COVID drug priced at Rs 990

Bengaluru: Defence Research and Development Organisation's (DRDO) anti-Covid-19 drug will be sold at Rs. 990 per sachet by Dr Reddy's Laboratories (DRL), officials said on Friday. The Hyderabad-based pharma company, however, will provide the medicine to the Central and state governments at a discounted price. 

The first batch of the drug was released on May 17 by Defence Minister Rajnath Singh and Health Minister Dr Harsh Vardhan, after the Drugs Controller General of India gave emergency use authorisation for 2-deoxy-D-glucose (2-DG), anti-viral drug as an adjunct therapy for moderate to severe Covid-19 patients. 

In April last year when the pandemic broke out, scientists of the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO conducted laboratory experiments with the help of the Centre for Cellular and Molecular Biology (CCMB), Hyderabad in collaboration with DRL and found that this molecule works effectively against the SARS-CoV-2 virus and inhibits viral growth.

The 2-DG drug comes in powder form in a sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production. 

Its selective accumulation in virally infected cells makes this drug unique. The drug reportedly reduces a patient's average recovery time by two and a half days and oxygen demand by upto 40 per cent, the Union Health Ministry said. 

(ANI)

12:39 May 28

DRDO's anti-COVID drug priced at Rs 990

Bengaluru: Defence Research and Development Organisation's (DRDO) anti-Covid-19 drug will be sold at Rs. 990 per sachet by Dr Reddy's Laboratories (DRL), officials said on Friday. The Hyderabad-based pharma company, however, will provide the medicine to the Central and state governments at a discounted price. 

The first batch of the drug was released on May 17 by Defence Minister Rajnath Singh and Health Minister Dr Harsh Vardhan, after the Drugs Controller General of India gave emergency use authorisation for 2-deoxy-D-glucose (2-DG), anti-viral drug as an adjunct therapy for moderate to severe Covid-19 patients. 

In April last year when the pandemic broke out, scientists of the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO conducted laboratory experiments with the help of the Centre for Cellular and Molecular Biology (CCMB), Hyderabad in collaboration with DRL and found that this molecule works effectively against the SARS-CoV-2 virus and inhibits viral growth.

The 2-DG drug comes in powder form in a sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production. 

Its selective accumulation in virally infected cells makes this drug unique. The drug reportedly reduces a patient's average recovery time by two and a half days and oxygen demand by upto 40 per cent, the Union Health Ministry said. 

(ANI)

Last Updated : May 28, 2021, 6:41 PM IST
ETV Bharat Logo

Copyright © 2024 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.